Hyogo, Japan

Takashi Yurube

This inventor holds 1 USPTO granted patent. Top assignee: Kinki University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Yurube. Retrieved from https://idiyas.com/inventor/takashi-yurube

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Yurube: Innovator in Intervertebral Disc Degeneration Treatment

Introduction

Takashi Yurube is a prominent inventor based in Hyogo, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of intervertebral disc degeneration. His innovative approach has the potential to improve the quality of life for many individuals suffering from this condition.

Latest Patents

Takashi Yurube holds a patent for a therapeutic agent aimed at treating intervertebral disc degeneration. This patent, which includes a material for culturing intervertebral disc cells, features LASCol obtained by enzymatically cleaving a terminus of collagen. This groundbreaking work represents a significant advancement in therapeutic options for patients.

Career Highlights

Yurube is affiliated with Kinki University, where he conducts research and develops innovative solutions in the medical field. His dedication to advancing medical science is evident in his focused research on intervertebral disc health.

Collaborations

Throughout his career, Takashi Yurube has collaborated with notable colleagues, including Saori Kunii and Kaoru Omae. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments.

Conclusion

In summary, Takashi Yurube is a key figure in the innovation of therapeutic agents for intervertebral disc degeneration. His work at Kinki University and his patent contributions highlight his commitment to improving medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…